Tara Henderson
Family · Oklahoma City, OKNPI 1548789688
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $469 and has fallen 72.1% since, to $131 in 2025.
Across 77 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$157
- Supernus Pharmaceuticals, Inc.$126
- Pfizer$95
- Sanofi Pasteur Inc.$85
- Corium, LLC$79
- Seqirus USA Inc$72
- plus $797 from 23 others
What the payments were for
- Food & beverage$1,411100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 4 | $157 |
| Supernus Pharmaceuticals, Inc. | 6 | $126 |
| Pfizer | 6 | $95 |
| Sanofi Pasteur Inc. | 5 | $85 |
| Corium, LLC | 4 | $79 |
| Seqirus USA Inc | 4 | $72 |
| Sanofi-aventis U.S. LLC | 4 | $60 |
| Astellas Pharma US Inc | 4 | $58 |
| Sobi, Inc | 4 | $58 |
| AstraZeneca | 2 | $55 |
| Merck | 4 | $55 |
| Amarin Pharma, Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Novo Nordisk | 4 | $49 |
| Alk-abello, Inc | 2 | $43 |
| Boehringer Ingelheim | 3 | $40 |
| Cranial Technologies, Inc | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| QOL Medical, LLC | 1 | $29 |
| AbbVie | 1 | $28 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Biomerieux Inc | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Amgen | 1 | $11 |
How this compares
$1,411 in reported general payments places this provider in the 75th percentile of 2,026 family providers in Oklahoma.
Other family in Oklahoma City
- April WilcoxOklahoma City$245K
- Jeremy MorganOklahoma City$63K
- Samantha BellingerOklahoma City$39K
- Lacey HillOklahoma City$20K
- Julia John SamuelOklahoma City$17K
- Kristina SnyderOklahoma City$15K
- Lindi CiglarOklahoma City$15K
- Shymol JohnOklahoma City$14K
- Xiomara PorrasOklahoma City$12K
- Anne DudeOklahoma City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.